CSLLYCIK 1274152

CSL LTD

EDGAR filings

Customers

None disclosed

Suppliers

1 active

Top supplier share

80%

of ARCT revenue · FY to 2025-12-31

Top supplier by $

$65.6M

ARCT · FY to 2025-12-31

Latest period

Dec 31, 2025

10-K filed 2026-03-03

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available). Thin bands are named without a figure. Click a band to open its filing.

Suppliers 1

Companies that disclose CSLLY as a major customer, as a share of their own revenue. 1 active, 0 lapsed.

Company	% of their revenue	Est. $ from CSLLY	Period	Trend	Status	Source
ARCT Arcturus Therapeutics Holdings Inc.	80%	$65.6M	FY 2025-12-31	−11.0pp	Active	10-K 2026-03-03
For the year ended December 31, 2025: •CSL – 80% of total revenue •BARDA – 16% of total revenueFor the year ended December 31, 2024: •CSL – 91% of total revenue For the year ended December 31, 2023: •CSL – 92% of total revenue Given this concentration, the Company’s financial performance and cash flows may be materially impacted if there are changes in demand, contract renewals, or the financial condition of these key customers. 10-K filed 2026-03-03 Period FY 2025-01-01 to 2025-12-31 (80%), FY 2024-01-01 to 2024-12-31 (91%), FY 2023-01-01 to 2023-12-31 (92%)Accession 0001193125-26-088391

Alerts are coming

Get an email when CSLLY's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.